SUN-650 Molecular Determinants of PARP1 Catalytic Activity and Substrate Selection in Adipocytes

Abstract Disclosure: W. Song: None. T.S. Nandu: None. W.L. Kraus: SigmaMillipore. Adipogenesis is a complex and tightly regulated process that plays a vital role in multiple aspects of human health. We have previously shown that ADP-ribosylation (ADPRylation), a posttranslational modification of proteins, regulates multiple steps during the differentiation of preadipocytes to adipocytes. Enzymes of the PARP family catalyze the covalent attachment of ADP-ribose units from NAD+ on specific amino acid acceptors in proteins. PARP1-mediated, site-specific ADP-ribosylation on substrate proteins controls multiple components of the proadipogenic gene regulatory machinery, including histone H2B and the transcription factor C/EBPβ. Our recent studies have revealed that small nucleolar RNAs (snoRNAs) can activate PARP1 catalytic activity in a DNA-independent manner. Moreover, the depletion of PARP1-interacting snoRNAs enhance the expression of adipocyte marker genes upon differentiation. We hypothesize that snoRNA-activated PARP1 ADPRylates its substrate proteins in a site-specific manner to control adipogenesis. Using an NAD+ analog-sensitive PARP1 approach with a “clickable” NAD+ analog and copper-catalyzed azide-alkyne cycloaddition (“click chemistry”) developed in our lab, we identified substrate proteins ADPRylated by snoRNA-activated PARP1, including several transcription factors. These results suggest that snoRNA-activated PARP1 can regulate gene expression by ADPRylating these transcription factors. We are currently determining how snoRNA-activated PARP1 selects its substrates for modification. Ongoing investigations are exploring (1) the molecular and biochemical mechanisms of the snoRNA-mediated PARP1 catalytic activity and (2) the regulatory roles of the snoRNA-activated PARP1 and its substrate proteins during adipogenesis. Collectively, these studies will explore snoRNA-mediated PARP1 activation and site-specific ADPRylation of key substrate proteins, which will provide insights into the role of PARP1 in the regulation of adipogenesis. Presentation: Sunday, July 13, 2025

Authors

Institutions

Publication Details

Journal
Journal of the Endocrine Society
Published
2025-10-01
DOI
https://doi.org/10.1210/jendso/bvaf149.160
Primary Topic
Computational Drug Discovery Methods
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SUN-650 Molecular Determinants of PARP1 Catalytic Activity and Substrate Selection in Adipocytes

W. Lee Kraus, Tulip Sunil Nandu, Weidan Song
Journal of the Endocrine Society
Computational Drug Discovery Methods
article

SUN-650 Molecular Determinants of PARP1 Catalytic Activity and Substrate Selection in Adipocytes

W. Lee Kraus, Tulip Sunil Nandu, Weidan Song
article en

Abstract

Abstract Disclosure: W. Song: None. T.S. Nandu: None. W.L. Kraus: SigmaMillipore. Adipogenesis is a complex and tightly regulated process that plays a vital role in multiple aspects of human health. We have previously shown that ADP-ribosylation (ADPRylation), a posttranslational modification of proteins, regulates multiple steps during the differentiation of preadipocytes to adipocytes. Enzymes of the PARP family catalyze the covalent attachment of ADP-ribose units from NAD+ on specific amino acid acceptors in proteins. PARP1-mediated, site-specific ADP-ribosylation on substrate proteins controls multiple components of the proadipogenic gene regulatory machinery, including histone H2B and the transcription factor C/EBPβ. Our recent studies have revealed that small nucleolar RNAs (snoRNAs) can activate PARP1 catalytic activity in a DNA-independent manner. Moreover, the depletion of PARP1-interacting snoRNAs enhance the expression of adipocyte marker genes upon differentiation. We hypothesize that snoRNA-activated PARP1 ADPRylates its substrate proteins in a site-specific manner to control adipogenesis. Using an NAD+ analog-sensitive PARP1 approach with a “clickable” NAD+ analog and copper-catalyzed azide-alkyne cycloaddition (“click chemistry”) developed in our lab, we identified substrate proteins ADPRylated by snoRNA-activated PARP1, including several transcription factors. These results suggest that snoRNA-activated PARP1 can regulate gene expression by ADPRylating these transcription factors. We are currently determining how snoRNA-activated PARP1 selects its substrates for modification. Ongoing investigations are exploring (1) the molecular and biochemical mechanisms of the snoRNA-mediated PARP1 catalytic activity and (2) the regulatory roles of the snoRNA-activated PARP1 and its substrate proteins during adipogenesis. Collectively, these studies will explore snoRNA-mediated PARP1 activation and site-specific ADPRylation of key substrate proteins, which will provide insights into the role of PARP1 in the regulation of adipogenesis. Presentation: Sunday, July 13, 2025

Journal of the Endocrine SocietyVol. 9(Supplement_1)
The University of Texas Southwestern Medical Center (US)
Openalex Percentile: Top 68%
Computational Drug Discovery Methods
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.